after streptozotocin (STZ), and the treatment with nicotinamide before STZ-injection abolished the increase of HbA1 in both STZ treated intact and thyroidectomized rats (2) . The present study deals with the short and semi long-term effects of experimental diabetes on the HbA1 and species differences between mice and rats with regard to these effects. Male ddY mice and Wistar-Imamichi rats were housed in an air-conditioned room (temperature 22±2'C, humidity 55+5%) with As shown in Fig. 1 , the increase in body weight was much reduced after STZ injection in mice (A) and rats (B) throughout the experimental period.
The mean plasma glucose concentrations were 500 and 650 mg/dl in diabetic rats and mice, respectively, which were quite high compared to the levels in control animals ( Fig. 2A, B) . HbA1 values were also significantly increased in diabetic mice and rats throughout the experimental period; control animals averaged 1.6-3.0% of total Hb, while mean values in diabetic animals were in the range of 3.2-4.3% until 8 weeks following the injection of STZ. However, the HbA1 value in mice (8.234+ 0.43%) was significantly higher than that found in rats (3.597+0.089%) after 9 weeks of STZ, and it was more than two-fold higher than that found in 8 weeks of STZ-diabetic mice.
It has recently been reported that HbA1 values of alloxan or STZ-diabetic rats are about 4% at 8 and 12 months following the induction of diabetes (3). This value is very Fig. 2 . Changes in glycosylated hemoglobin A, (HbA,) and blood glucose (mean±S.E.) in intact, buffer and streptozotocin treated diabetic mice (A) and rats (B). Numbers of animals in each group are indicated at the base of each column.
I: intact group, B: citrate buffer treated group, S: streptozotocin treated group. AGE 6W: non-treated group, 8W: the group with two weeks after streptozotocin, 10W: the group with four weeks after streptozotocin, 1 2W: the group with six weeks after streptozotocin, 14W: the group with eight weeks after streptozotocin, 1 5W: the group with nine weeks after streptozotocin. P values were calculated by Student's t-test. **P<0.01 : buffer group vs. streptozotocin group in mice and rats. close to our data obtained from STZ-treated rats at 8 or 9 weeks of diabetes. Therefore, the unexpectedly high value of HbA1 observed in STZ-diabetic mice at 9 weeks is noteworthy.
However, it is not clear from our experimental conditions whether such a phenomenon is continuous or transient. The present results together with our previous paper (2) provides fundamental data for changes in HbA1 which have not been so intensively studied in the laboratory animals. On the other hand, they suggest that further long-term experiments are required for judging the species difference between mice and rats in the diabetic state.
